Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus.
about
Strategies in the development of vaccines to prevent infections with group A streptococcusCorrelates of Protection for M Protein-Based Vaccines against Group A StreptococcusStructure-Informed Design of an Enzymatically Inactive Vaccine Component for Group A StreptococcusPathogenesis of group A streptococcal infectionsSurface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope.Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.Impact of M49, Mrp, Enn, and C5a peptidase proteins on colonization of the mouse oral mucosa by Streptococcus pyogenes.Characterization of the streptococcal C5a peptidase using a C5a-green fluorescent protein fusion protein substrate.Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization.Humanized in vivo model for streptococcal impetigoAntibody against surface-bound C5a peptidase is opsonic and initiates macrophage killing of group B streptococci.Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.M(+) group a streptococci are phagocytized and killed in whole blood by C5a-activated polymorphonuclear leukocytes.Active and passive intranasal immunizations with streptococcal surface protein C5a peptidase prevent infection of murine nasal mucosa-associated lymphoid tissue, a functional homologue of human tonsils.Group A Streptococcus secreted esterase hydrolyzes platelet-activating factor to impede neutrophil recruitment and facilitate innate immune evasionProtease-armed bacteria in the skin.Differential recognition of surface proteins in Streptococcus pyogenes by two sortase gene homologs.Disease manifestations and pathogenic mechanisms of Group A Streptococcus.Postgenomic analysis of four novel antigens of group a streptococcus: growth phase-dependent gene transcription and human serologic response.Defense from the Group A Streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor.Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenesActive and passive immunizations with the streptococcal esterase Sse protect mice against subcutaneous infection with group A streptococciPredicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate.Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus case.Identification of the Streptococcus pyogenes surface antigens recognised by pooled human immunoglobulinCo-Activation of Th17 and Antibody Responses Provides Efficient Protection against Mucosal Infection by Group A Streptococcus.Identifying protective Streptococcus pyogenes vaccine antigens recognized by both B and T cells in human adults and children.Regulation of inhibition of neutrophil infiltration by the two-component regulatory system CovRS in subcutaneous murine infection with group A streptococcusDevelopment of a multicomponent vaccine for Streptococcus pyogenes based on the antigenic targets of IVIG.Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease ModelsThe fibrinogen-binding M1 protein reduces pharyngeal cell adherence and colonization phenotypes of M1T1 group A Streptococcus.Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP.Multi-functional mechanisms of immune evasion by the streptococcal complement inhibitor C5a peptidase.Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice.Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response.Structural heterogeneity of the streptococcal C5a peptidase gene in Streptococcus pyogenes.Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.Identification of B- and T-cell epitopes within the fibronectin-binding domain of the SfbI protein of Streptococcus pyogenes.Towards developing a vaccine for rheumatic heart disease.Human serum induces streptococcal c5a peptidase expression.
P2860
Q26863366-F5BA9BAB-6320-40D5-A067-531C209B8AACQ27009175-A900D82A-A172-4920-B630-0DBD235C987AQ27679389-C87CC134-0329-45AC-9109-7758C56B286EQ29615547-5ADB21FB-E661-4B94-860C-D9627E059C75Q33538951-FF4D0100-21DD-4129-B647-4150036B8748Q33719415-40AE5B8D-D7D2-4481-8767-F2A26B78F9C0Q33767819-BAF5E1E5-E066-4419-B1BF-4CC69B01C4DFQ33901765-87FDBD1E-B107-4068-A63D-4BB2BB7190FAQ34003189-5303999A-3FB2-4820-86BE-F24C1B1FCEF7Q34004420-F608C0B9-596D-4AFE-8963-5CA1BF39071DQ34006819-FE2D4BF1-A9AD-4F40-AB48-6697DDCD7618Q34112608-762F811D-03B4-4AC4-8E14-50C6E71D6372Q34116464-568B8858-334E-4E40-87D8-6D48304EBC40Q34194488-71FB1B46-8DBE-4312-B8F7-F19E6C315EE4Q34229649-CA0BE899-FF76-434D-9A20-B4205CAAF485Q34256463-6C9E3C6B-E7FE-4579-AC55-E22B43F0178DQ34309446-1D4FC9F2-9173-4D13-98F9-CC66BFC731F6Q34413457-24822094-C7E0-4D2A-AF2D-CA45BE320337Q34839724-EDD09C07-9499-4751-A955-5FC2AAAE3824Q34988307-39BAD9AD-D19A-4328-BB96-8B0F78A35A0CQ35133183-6D674D27-9C6F-41C8-BDB6-9E8DD2113097Q35913574-36C7B5E6-4484-4816-B724-E27408D37485Q36054412-3888C2DD-D0D4-494C-B6C2-884E8D1152A7Q36208963-C9450522-B6EA-4BBB-99D1-06FBF1C7F823Q36216880-269D90B2-F0E4-4020-B65A-BA2514B5CBE4Q36234877-0C7039B8-F0C4-42A2-983F-33C19B1721A5Q36616151-A62BFBA9-7FE0-4CE4-8B2B-7D19CE998489Q36646612-D2B4FDD0-037E-4CFA-87A6-BF43974F880FQ36698378-C2B3E70D-8184-4344-BB9C-72F3B5646FF7Q37027300-EBB1BAA5-C29F-4C3C-89AB-4B962DDF2B78Q37563501-760CE064-453E-418E-8B05-6C1C7E27776FQ37657138-BF913837-2728-4A5A-8013-AE8B2AC96D07Q38625811-A517B8F7-F237-4C63-824E-EBAF9D4FAFF8Q39510467-DE078D4F-D66C-442B-A3C0-F933797C9308Q39518108-5FCA4154-BA6C-431E-A1CA-35F0E45B67E2Q39741374-062B25D3-B19E-43CA-825C-B9FB97FB30AFQ39863755-70C8BFB9-786C-45DE-8AF2-8F139AC9871BQ40403892-AFA07B5A-6023-489B-A13C-08AC1A0C0EA0Q41928281-E32EF553-8EA5-4028-AA16-ABFEF241FA30Q41958835-E9321900-1E39-4552-BA79-41AD58A2D6F4
P2860
Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Intranasal immunization with C ...... by the group A Streptococcus.
@ast
Intranasal immunization with C ...... by the group A Streptococcus.
@en
type
label
Intranasal immunization with C ...... by the group A Streptococcus.
@ast
Intranasal immunization with C ...... by the group A Streptococcus.
@en
prefLabel
Intranasal immunization with C ...... by the group A Streptococcus.
@ast
Intranasal immunization with C ...... by the group A Streptococcus.
@en
P2093
P2860
P1476
Intranasal immunization with C ...... by the group A Streptococcus.
@en
P2093
P2860
P304
P407
P577
1997-06-01T00:00:00Z